Overall survival of 130 patients with primary spinal glioblastomas /- sarcomas reported in literature until March 2015.

<p>In 27 of the 157 patients (17%) survival data were not available.</p

Age distribution of 157 patients with primary spinal origin reported in literature until March 2015.

<p>It is displayed in the form of a histogram. Median age at diagnosis was 22 years.</p

Overall survival (OS) according to the publications before and after 1980.

<p>A modest increase in treatment success has been achieved over recent decades.</p

Impact of age on overall survival (OS).

<p>On univariate analysis the older patients (≥ 60 years at initial diagnosis) had significantly shorter survival times (p < 0.0001).</p

Procedure of publication retrieval and in- and exclusion of cases displayed in a PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow chart (4).

<p>Procedure of publication retrieval and in- and exclusion of cases displayed in a PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow chart (4).</p

S1 Dataset -

(PDF)</p

Changes in radical prostatectomies.

(A) Overall numbers of radical prostatectomies classified as open, laparoscopic and robotic approaches and risk groups according to the D’Amico score (B).</p

Changes in fractionation.

Proportion of conventional fractionation versus hypofractionation (%) in the baseline week and throughout the pandemic.</p

Changes in prostate biopsies.

Total numbers of prostate biopsies performed in the baseline week and after the onset of the pandemic.</p

Cumulative numbers of PCa patients.

(A) Cumulative numbers of patients undergoing prostate cancer therapy either with radiotherapy or radical prostatectomy in 2019 vs. 2020. (B) Development of patient numbers after the beginning of the pandemic. The blue line demonstrates the 7-day incidence of COVID-19 in the corresponding week.</p